Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, August 26, 2021
[ Thu, Aug 26th 2021
] - WOPRAI
[ Thu, Aug 26th 2021
] - WOPRAI
[ Thu, Aug 26th 2021
] - WOPRAI
[ Thu, Aug 26th 2021
] - WOPRAI
Wed, August 25, 2021
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
[ Wed, Aug 25th 2021
] - WOPRAI
Yigal Nochomovitz Maintained (ARCT) at Strong Buy with Decreased Target to $114 on, Aug 25th, 2021
Yigal Nochomovitz of Citigroup, Maintained "Arcturus Therapeutics Holdings Inc." (ARCT) at Strong Buy with Decreased Target from $118 to $114 on, Aug 25th, 2021.
Yigal has made no other calls on ARCT in the last 4 months.
There are 5 other peers that have a rating on ARCT. Out of the 5 peers that are also analyzing ARCT, 0 agree with Yigal's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Yigal
- Steven Seedhouse of "Raymond James" Downgraded from Hold to Sell on, Thursday, August 12th, 2021
- Madhu Kumar of "Goldman Sachs" Downgraded from Hold to Strong Sell and Held Target at $29 on, Wednesday, August 11th, 2021
- Joel Beatty of "Baird" Downgraded from Hold to Sell on, Tuesday, August 10th, 2021
- Brian Cheng of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $85 on, Tuesday, August 10th, 2021
- Gena Wang of "Barclays" Downgraded from Hold to Sell and Decreased Target to $25 on, Monday, June 21st, 2021
